{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:47:47Z","timestamp":1793512067174,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:00:00Z","timestamp":1705190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jpba.2024.115975","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T21:15:57Z","timestamp":1705094157000},"page":"115975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Method development for the quantification of nine nitazene analogs and brorphine in Dried Blood Spots utilizing liquid chromatography \u2013 tandem mass spectrometry"],"prefix":"10.1016","volume":"241","author":[{"given":"Christina","family":"Ververi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Galletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Massano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Alladio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.115975_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jat\/bkaa115","article-title":"A 2017-2019 update on acute intoxications and fatalities from illicit fentanyl and analogs","volume":"45","author":"Brunetti","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib2","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2017.281626","article-title":"The fentanyl epidemic and evolution of fentanyl analogs in the United States and the European Union","volume":"65","author":"Jannetto","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2024.115975_bib3","unstructured":"European Union. European Monitoring Centre for Drugs and Drug Addiction., European drug report: trends and developments (2019)."},{"key":"10.1016\/j.jpba.2024.115975_bib4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF02161116","article-title":"Synthese basisch substituierter, analgetisch wirksamer benzimidazol-derivate","volume":"13","author":"Hunger","year":"1957","journal-title":"Experientia"},{"key":"10.1016\/j.jpba.2024.115975_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/dta.2738","article-title":"Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene","volume":"12","author":"Blanckaert","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.115975_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jat\/bkaa016","article-title":"Isotonitazene quantitation and metabolite discovery in authentic forensic casework","volume":"44","author":"Krotulski","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib7","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00204-022-03294-2","article-title":"First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass","volume":"96","author":"Vandeputte","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109263","article-title":"Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent \u03bc-opioid receptor agonists","volume":"221","author":"De Luca","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpba.2024.115975_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FTD.0000000000000970","article-title":"Acute intoxications and fatalities associated with benzimidazole opioid (nitazene analog) use: a systematic review","volume":"44","author":"Montanari","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.115975_bib10","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1093\/jat\/bkac023","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2017\u20132020: a review","volume":"46","author":"Mohr","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-023-06451-2","article-title":"Alkoxy chain length governs the potency of 2-benzylbenzimidazole \u2018nitazene\u2019 opioids associated with human overdose","volume":"240","author":"Glatfelter","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpba.2024.115975_bib12","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1093\/jat\/bkac062","article-title":"Intoxications in an Australian emergency department involving \u2018nitazene\u2019 benzylbenzimidazole synthetic opioids (etodesnitazene, butonitazene and protonitazene)","volume":"47","author":"Schumann","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110686","article-title":"Isotonitazene: fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland","volume":"320","author":"Mueller","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.115975_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jat\/bkab117","article-title":"A forward-thinking approach to addressing the new synthetic opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography-tandem quadrupole mass spectrometry (LC-QQQ-MS)","volume":"46","author":"Walton","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110989","article-title":"Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework","volume":"327","author":"Grafinger","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.115975_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jat\/bkab082","article-title":"The rise and fall of isotonitazene and brorphine: two recent stars in the synthetic opioid firmament","volume":"46","author":"Vandeputte","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib17","unstructured":"Drug Enforcement Administration, Diversion Control Division, Drug & Chemical Evaluation Section, Benzimidazole-Opioids, Other Name: Nitazenes, \u3008https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/benzimidazole-opioids.pdf\u3009, 2022 (accessed 24 October 2023)."},{"key":"10.1016\/j.jpba.2024.115975_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2024.115975_bib19","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2022.36.S1.R4024","article-title":"Nitazenes are potent mu\u2010opioid receptor agonists with profound respiratory depression","volume":"36","author":"Palkovic","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.jpba.2024.115975_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107121","article-title":"Mu-opioid receptor selective superagonists produce prolonged respiratory depression","volume":"26","author":"Malcolm","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jpba.2024.115975_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.legalmed.2023.102216","article-title":"Postmortem examination and toxicological analysis for acute metonitazene intoxication in Japan: a case report","volume":"61","author":"Morioka","year":"2023","journal-title":"Leg. Med."},{"key":"10.1016\/j.jpba.2024.115975_bib22","first-page":"1","article-title":"Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City","volume":"00","author":"Pardi","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.858234","article-title":"Synthetic benzimidazole opioids: the emerging health challenge for european drug users","volume":"13","author":"Di Trana","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2024.115975_bib24","unstructured":"European Monitoring Center for Drugs and Drug Addiction, European Drug Report 2023: Trends and Developments, \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug\u3009\u3008-\u3009 report\/2023_en, 2023 (accessed October 2023)."},{"key":"10.1016\/j.jpba.2024.115975_bib25","article-title":"Recent advances in the detection of drugs of abuse by dried blood spots","volume":"37","author":"Ververi","year":"2022","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2024.115975_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10408444.2011.650790","article-title":"Dried blood spots in toxicology: From the cradle to the grave?","volume":"42","author":"Stove","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/FTD.0b013e31818d9fdb","article-title":"Determination of morphine and 6-acetylmorphine in blood with use of dried blood spots","volume":"30","author":"Garcia Boy","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.115975_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jpba.2017.02.046","article-title":"Dried blood spots combined to an UPLC\u2013MS\/MS method for the simultaneous determination of drugs of abuse in forensic toxicology","volume":"147","author":"Sadler Sim\u00f5es","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.115975_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1373\/clinchem.2010.152124","article-title":"Oral fluid testing: promises and pitfalls","volume":"57","author":"Huestis","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2024.115975_bib30","first-page":"80","article-title":"Analysis of dried blood spots in forensic toxicology","author":"Watterson","year":"2015","journal-title":"N. Sampl. Strateg. Toxicol. Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.115975_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jat\/bky074","article-title":"Fully automated forensic routine dried blood spot screening for workplace testing","volume":"43","author":"Gaugler","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123265","article-title":"Development and validation of a UHPLC-HRMS-QTOF method for the detection of 132 new psychoactive substances and synthetic opioids, including fentanyl, in dried blood spots","volume":"241","author":"Massano","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.115975_bib33","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.1021\/acs.analchem.8b03512","article-title":"Evaluation of the capitainer-B microfluidic device as a new hematocrit-independent alternative for dried blood spot collection","volume":"90","author":"Velghe","year":"2018","journal-title":"Anal. Chem."},{"issue":"215","key":"10.1016\/j.jpba.2024.115975_bib34","article-title":"Effective validation of chromatographic analytical methods: the illustrative case of androgenic steroids","author":"Alladio","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.115975_bib35","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","volume":"86","author":"Gu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.115975_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/ac60290a013","article-title":"Decision and detection limits for linear calibration curves","volume":"42","author":"Hubauxl","year":"1970","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.115975_bib37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","year":"2013","journal-title":"J. Anal. Toxicol."},{"issue":"2023","key":"10.1016\/j.jpba.2024.115975_bib38","first-page":"1","article-title":"High-throughput quantification of emerging \u2018nitazene\u2019 benzimidazole opioid analogs by microextraction and UHPLC-MS-MS","author":"Sch\u00fcller","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115975_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.17145\/jab.15.007","article-title":"Dried blood spot analysis; facing new challenges","volume":"1","author":"Koster","year":"2015","journal-title":"J. Appl. Bioanal."},{"key":"10.1016\/j.jpba.2024.115975_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2016.02.001","article-title":"Detection of \u2018bath salts\u2019 and other novel psychoactive substances in hair samples of ecstasy\/MDMA\/\"Molly\" users","volume":"161","author":"Palamar","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2024.115975_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2017.07.010","article-title":"Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene","volume":"48","author":"Palamar","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jpba.2024.115975_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/00952990.2018.1550652","article-title":"Testing hair for fentanyl exposure: a method to inform harm reduction behavior among individuals who use heroin","volume":"45","author":"Palamar","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.jpba.2024.115975_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9422","article-title":"Development of a rapid, in-situ analysis method using sheath-flow probe electrospray ionisation-mass spectrometry for the direct identification of cocaine metabolites in dried blood spots","volume":"37","author":"Kim","year":"2023","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:37:29Z","timestamp":1760002649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"alternative-id":["S0731708524000153"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.115975","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Method development for the quantification of nine nitazene analogs and brorphine in Dried Blood Spots utilizing liquid chromatography \u2013 tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.115975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115975"}}